Ординатура / Офтальмология / Английские материалы / Principles Of Medical Statistics_Feinstein_2002

Hennekens, C.H., Speizer, F.E., Rosner, B., Bain, C.J., Belanger, C., and Peto, R. Use of permanent hair dyes and cancer among registered nurses. Lancet 1979; 1:1390–1393. [25]

Herbst, A.L., Kurman, R.J., Scully, R.E., and Poskanzer, D.C. Clear cell adenocarcinoma of the genital tract in young females: Registry report. N. Engl. J. Med. 1972; 287:1259–1264. [17]

Herrnstein, R.J. and Murray, C. The Bell Curve: Intelligence and Class Structure in American Life. New York: Free Press, 1994. [28]

Hill, A.B. The environment and disease: Association or causation. Proc. R. Soc. Med. 1965; 58:295–300. [25]

Hill, M.O. Correspondence analysis: A neglected multivariate method. Appl. Statist. 1974; 23:340–354. [28]

Hlatky, M.A., Pryor, D.B., Harrell, F.E. Jr. et al. Factors affecting the sensitivity and specificity of the exercise electrocardiogram: A multivariable analysis. Am. J. Med. 1984; 77:64–71. [21]

Hochberg, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75:800–802. [25]

Hogue, C. and Gaylor, D. Case-exposure studies: A new, simplified approach to relative risk. Am. J. Epidemiol. 1981; 114:427 (Abstract). [17]

Hogue, C.J.R., Gaylor, D.W., and Schulz, K.F. Estimators of relative risk for case-control studies. Am. J. Epidemiol. 1983; 118:396–407. [17]

Holford, T.R. The estimation of age, period, and cohort effects for vital rates. Biometrics 1983; 39:311–324. [22]

Holford, T.R. An alterative approach to statistical age-period-cohort analysis. J. Chronic Dis. 1985; 38:831–836. [22]

Hollander, J. Types of Shape. New Haven: Yale University Press, 1991. [9]

Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979; 6:65–70. [25] Hoover, D.R., Extension of the life table to repeating and changing events. Am. J. Epidemiol. 1996;

143:1266–1276. [22]

Hoover, R.N. and Strasser, P.H. Artificial sweetners and human bladder cancer: Preliminary results. Lancet 1980; 1:837–840. [25]

Horwitz, R.I. and Feinstein, A.R. Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy. Am. J. Med. 1986; 81:503–507. [19]

Hospital Association of New York State. Compendium of Clinical Protocols, Criteria and Efficacy Research — Guidelines and Ongoing Research. Albany, NY: Hospital Association of New York State; October 1989. [21]

Hourani, L.L., Jakowatz, J., Goodman, M., Mueller, G., Brodie, G., and Jaffery, A. Concordance of hospital cancer registryand physician-collected data for patients with melanoma. J. Natl. Cancer Instit. 1992; 84:1749–1750. [20]

Howell, E.M. and Blondel, B. International infant mortality rates: Bias from reporting differences. Am. J. Public Health. 1994; 84:850–852. [17]

Hsieh, C.C., MacMahon, B., Yen, S., Trichopoulus, D., Warren, K., and Nardi, G. Coffee and pancreatic cancer. Chapter 2 (Letter to editor). N. Engl. J. Med. 1986; 315:587–589. [25]

Hsieh, H-K. Chinese tally mark. Am. Statist. 1981; 35:174. [2]

Hull, R., Hirsh, J., and Sackett, D. The use of long-term outcome to validate diagnostic approaches to patients with clinically suspected recurrent deep venous thrombosis. Clin. Res. 1983; 31:234A (Abstract). [21]

Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., and Newman, T.B. Designing Clinical Research. 2nd ed. Philadelphia: Lippincott Williams & Wilkens, 2000. [1]

Huskisson, E.C. Measurement of pain. Lancet 1974; 2:1127–1131. [15]

Irwin, J.O. Tests of significance for differences between percentages based on small numbers. Metron 1935; 12:83–94. [12]

Jacobsen, S.J., Girman, C.J., Guess, H.A., Oesterling, J.E., and Lieber, M.M. A population-based study of aging and prostatism: Do longitudinal changes in urinary symptom frequency match crosssectional estimates? J. Gen. Int. Med. 1995; 10:44 (Abstract). [22]

Jacobson, R.M. and Feinstein, A.R. Oxygen as a cause of blindness in premature infants: “Autopsy” of a decade of errors in clinical epidemiologic research. J. Clin. Epidemiol. 1992; 45:1265–1287. [23]

© 2002 by Chapman & Hall/CRC

Jaeschke, R., Guyatt, G.H., and Sackett, D.L. User’s guide to the medical literature III. How to use an article about a diagnostic test. A. Are the results of the study valid? JAMA 1994; 271:389–391. B. What are the results and will they help me in caring for my patients? JAMA 1994; 271:703–707. [21]

Jeffries, J.A., Robboy, S.J., O’Brien, P.C. et al. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am. J. Obstet. Gynecol. 1984; 148:59–66. [25]

Jenkins, J. Investigations: How to get from guidelines to protocols (Editorial). Br. Med. J. 1991; 303:323–324. [21]

Jones, A.W. and Jonsson, K.A. Between-subject and within-subject variations in the pharmacokinetics of ethanol. Br. J. Clin. Pharmac. 1994; 42:427–431. [29]

Jones, B., Jarvis, P., Lewis, J.A., and Ebbutt, A.F. Trials to assess equivalence: The importance of rigorous methods. Br. Med. J. 1996; 313:36–39. [24]

Jones, C.P. Living beyond our “means”: New methods for comparing distributions. Am. J. Epidemiol. 1997; 146:1056–1066. [16]

Juniper, E.F., Guyatt, G.H., Streiner, D.L., and King, D.R. Clinical impact versus factor analysis for quality of life questionnaire construction. J. Clin. Epidemiol. 1997; 50:233–238. [28]

Kadel, C., Vallbracht, C., Buss, F., Kober, G., and Kaltenbach, M. Long-term follow-up after percutaneous transluminal coronary angioplasty in patients with single-vessel disease. Am. Heart J. 1992; 124:1159–1169. [22]

Kahaleh, M.B. and LeRoy, E.C. Interleukin-2 in scleroderma: Correlation of serum level with extent of skin involvement and disease duration. Ann. Intern. Med. 1989; 110:446–450. [19]

Kahn, H.A. and Dawber, T.R. The development of coronary heart disease in relation to sequential biennial measures of cholesterol in the Framingham Heart Study. J. Chronic Dis. 1966; 19:61–620. [22]

Kahn, H.A. and Sempos, C.T. Statistical Methods in Epidemiology. New York: Oxford University Press, 1989. [26]

Kallen, A and Larsson, P. Dose response studies: How do we make them conclusive? Statist. Med. 1999; 18:629–641. [27]

Kantor, S., Winkelstein, W., Jr., Sackett, D.L. et al. A method for classifying blood pressure: An empirical approach to reduction of misclassification due to response instability. Am. J. Epide - miol. 1966; 84:510–523. [15]

Kaplan, E.L. This week’s citation classic. Current Contents 1983; No. 24(June 13):14. [22]

Kaplan, E.L. and Meier, P. Non-parametric estimation from incomplete observations. J. Am. Statist. Assn. 1958; 53:457–481. [22]

Katz, D., Baptista, J., Azen, S.P., and Pike, M.C. Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics 1978; 34:469–474. [17]

Katz, J. and Sommer, A. Reliability indexes of automated perimetric tests. Arch. Ophthalmol. 1988; 106:1252–1254. [21]

Kauffman, G.R., Wenk, M., Taeschner, W. et al. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus. Clin. Pharm. Therap. 1996; 60:62–67. [9]

Keelan, P. Double-blind trial of propranolol (Inderal) in angina pectoris. Br. Med. J. 1965; 1:897–898. [15]

Kempthorne, O. Inference from experiments and randomization. In Srivasta, J.N. (Ed.). A Survey of Statistical Design and Linear Models. North Holland: Amsterdam, 1975. [21]

Kendall, M.G. Rank Correlation Methods. 2nd ed. London: Charles W. Griffin & Co., 1955. [27] Kendall, M.G. A Course in Multivariate Analysis. London: C. Griffin & Co., 1968. [28]

Kendall, M.G. and Buckland, W.R. A Dictionary of Statistical Terms. 3rd ed. New York: Hafner Publishing Co., 1971. [2]

Kendall, M.G. and Gibbons, J.D. Rank Correlation Methods. 5th ed. London: Oxford, 1990. [27] Kendall, M.G. and Stuart, A. Advanced Theory of Statistics. Vol. 2. Inference and Relationship. 3rd

ed. London: Griffin, 1973. [11,23]

Kernan, W.N., Feinstein, A.R., and Brass, L.M. A methodological appraisal of research on prognosis after transient ischemic attacks. Stroke 1991; 22:1108–1116. [22]

© 2002 by Chapman & Hall/CRC

Keuls, M. The use of the studentized range in connection with the analysis of variance. Euphytica 1952; 1:112–122. [25]

Kirshner, B. Methodological standards for assessing therapeutic equivalence. J. Clin. Epidemiol. 1991; 44:839–849. [24]

Kitagawa, E.M. Theoretical considerations in the selection of a mortality index, and some empirical comparisons. Human Biol. 1966; 38:293–308. [26]

Kleinbaum, D.G., Kupper, L.L., and Morgenstern, H. Epidemiologic Research. Principles and Quan - titative Methods. Belmont, CA: Lifetime Learning Publications, 1982. [26]

Klinkenberg-Knol, E., Festen, H.P., Jansen, J.B. et al. Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann. Intern. Med. 1994:121:161–167. [15]

Knapen, M.H.J., Hamulyak, K., and Vermeer, C. The effect of vitamin K supplementation on circulating osteocalcin (bone gla protein) and urinary calcium excretion. Ann. Intern. Med. 1989; 111:1001–1005. [19]

Knaus, W.A., Wagner, D.P., Draper, E.A., Zimmerman, J.E., Bergner, M., Bastros, P.G. et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospital - ized adults. Chest 1991; 100:1619–1636. [21]

Knottnerus, J.A. and Leffers, P. The influence of referral patterns on the characteristics of diagnostic tests. J. Clin. Epidemiol. 1992; 45:1143–1154. [21]

Kochanek, K.D., Maurer, J.D., and Rosenberg, H.M. Why did black life expectancy decline from 1984 through 1989 in the United States? Am. J. Public Health 1994; 84:938–944. [22]

Kodlin, D. and Collen, M.F. Automated diagnosis in multiphasic screening. In Lacam, L.M., Neyman, J., and Scott, E.L. (Eds.). Proceedings of the Sixth Berkeley Symposium on Mathematical Statistics and Probability. Vol. IV: Biology and Health. Berkeley, CA: University of California Press, 1971. [21]

Kohout, F.J. Statistics for Social Scientists. A Coordinated Learning System. New York: John Wiley and Sons, 1974. [27]

Koivisto, P. and Miettinen, T.A. Long-term effects of ileal bypass on lipoproteins in patients with familial hypercholesterolemia. Circulation 1984; 70:290–296. [17]

Kolmogorov, A.N. Confidence limits for an unknown distribution function. Ann. Math. Statist. 1941; 12:461–463. [14]

Kong, A., Barnett, O., Mosteller, F., and Youtz, C. How medical professionals evaluate expressions of probability. N. Engl. J. Med. 1986; 315:740–744. [6]

Kraemer, H.C. Ramifications of a population model for κ as a coefficient of reliability. Psychometrika 1979; 44:461–472. [20]

Kramer, M.S. and Feinstein, A.R. Clinical biostatistics: LIV. The biostatistics of concordance. Clin. Pharmacol. Ther. 1981; 29:111–123. [20]

Kramer, M.S., Rooks, Y., and Pearson, H.A. Growth and development in children with sickle-cell trait. N. Engl. J. Med. 1978; 299:686–689. [24]

Krieger, K., Krieger, S., Jansen, O., Gass, P., Theilmann, L., and Lichtnecker, H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346:270–274. [15]

Krim, J. and Thomas, K. Resource utilization: A medical center cluster model. VA Practitioner 1987; 4:100–108. [28]

Kronmal, R.A. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial. J. Am. Med. Assn. 1985; 253:2091–2093. [23]

Kupper, L.L., Janis, J.M., Karmous, A., and Greenberg, B.G. Statistical age-period-cohort analysis: A review and critique. J. Chronic Dis. 1985; 38:811–830. [22]

Kupper, L.L., McMichael, A.J., Symons, M.J., and Most, B.M. On the utility of proportional mortality analysis. J. Chron. Dis. 1978; 31:15–22. [26]

Kupper, L.L., Stewart, J.R., and Williams, K.A. A note on controlling significance levels in stepwise regression. Am. J. Epidemiol. 1976; 103:13–15. [25]

Kurtzke, J.F. On estimating survival; A tale of two censors. J. Clin. Epidemiol. 1989; 42:169–175. [22] Labarthe, D., Adam, E., Noller, K.L. et al. Design and preliminary observations on National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet. Gynecol. 1978; 51:453–458. [17] Lachin, J.M. On a stepwise procedure for two population Bayes decision rules using discrete vari-

ables. Biometrics 1973; 29:551–564. [21]

© 2002 by Chapman & Hall/CRC

Lachs, M.S., Nachamkin, I., Edelstein, P., Goldman, J., Feinstein, A.R., and Schwartz, J.S. Spectrum bias in the evaluation of diagnostic tests: Lessons from the rapid dipstick test for urinary tract infection. Ann. Intern. Med. 1992; 117:135–140. [21]

Ladenheim, M.L., Kotler, T.S., Pollock, B.H., Berman, D.S., and Diamond, G.A. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am. J. Cardiol. 1987; 59:270–277. [21]

Lan, K.K.G., Simon, R., and Halperin, M. Stochastically curtailed tests in long-term clinical trials. Commun. Stat-Sequential Analysis 1982; 1:207–219. [25]

Landis, J.R. and Koch, G.G. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174. [20]

Lapedes, D.N. (Ed.). Dictionary of Scientific and Technical Terms. New York: McGraw-Hill, 1974. [2] Lapointe, F.J. and Legendre, P. A classification of pure malt Scotch whiskies. Appl. Statist. 1994;

43:237–257. [28]

Last, J.M. (Ed.). A Dictionary of Epidemiology. 2nd ed. New York: Oxford University Press, 1988. [17] Lauer, K. The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-

analytic study. J. Clin Epidemiol. 1993; 47:43–48. [28]

Laupacis, A., Sackett, D.L., and Roberts, R.S. An assessment of clinically useful measures of the consequences of treatment. N. Engl. J. Med. 1988; 318:1728–1733. [10]

Lee, J. Exact confidence interval of the SMR based on prevalence data (Letter to editor). Int. J. Epidemiol. 1994; 23:428–429. [26]

Lehmann, E.L. The Fisher, Neyman-Pearson theories of testing hypotheses: one theory or two? J.Am. Stat. Soc. 1993; 88:1242–1249. [23]

Leibovici, L., Samra, Z., Konigsberger, H., Drucker, M., Ashkenazi, S., and Pitlik, S. Long-term survival following bacteremia or fungemia. JAMA 1995; 274:807–812. [15]

Lelorier, J. et al, Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N. Engl. J. Med. 1997; 337:536–542. [25]

Lemna, W.K., Feldman, G.L., Kerem, B. et al. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N. Engl. J. Med. 1990; 322:291–296. [21]

Lentner, C. (Ed.). Geigy Scientific Tables. Vol. 2. 8th ed. Basle, Switzerland: Ciba-Geigy, 1982. [8,29] Levin, B. Annotation on the Holm, Simes and Hochberg multiple test procedures. Am. J. Public

Health 1996; 86:628–629. [25]

Levine, R.J., Hauth, J.C., Curet, L.B., Sibai, B.M., Catalano, P.M. et al. Trial of calcium to prevent preeclampsia. N. Engl. J. Med. 1997; 337:69–76. [25]

Lichtenstein, J.L., Feinstein, A.R., Suzio, K.D., DeLuca, V.A., Jr., and Spiro, H.M. The effectiveness of panendoscopy on diagnostic and therapeutic decisions about chronic abdominal pain. J. Clin. Gastroenterol. 1980; 2:31–36. [21]

Liddell, F.D.K. Simple exact analysis of the standardized mortality ratio. J. Epidemiol. Comm. Health 1984; 38:85–88. [26]

Lieberman, J., Schleissner, L.A., Nosal, A., Sastre, A., and Mishkin, F.S. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest 1983; 84:522–528. [22] Lindenbaum, J., Mellow, M.H., Blackstone. M.O., and Butler,V.P., Jr.Variation in biologic availability

of digoxin from four preparations. N. Engl. J. Med. 1971; 285:1344–1347. [24]

Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. JAMA, 1984; I. Reduction in incidence of coronary heart disease 251:351–364. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 365–374. [23]

Lipid Research Clinics Program. Reply to commentary by Richard Kronmal. JAMA 1985; 254:263–264. [23]

Liu, Q. An ordered-directed score test for trend in ordered 2 × K tables. Biometrics 1998; 54:1147–1154. [27]

Loewenson, R.B., Bearman, J.E., and Resch, J.A. Reliability of measurements for studies of cerebrovascular atherosclerosis. Biometrics 1972; 28:557–569. [20]

© 2002 by Chapman & Hall/CRC

Lorenz, W., Duda, D., Dick, W. et al. Incidence and clinical importance of perioperative histamine release: Randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 1994; 343:933–940. [20]

Luengo, M., Picado, C., Piera, C., Guanabens, N., Montserrat, J.M., Rivera, J., and Setoain, J. Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur. Respir. J. 1991; 4:441–444. [29]

Machin, D. and Gardner, M.J. Calculating confidence intervals for survival time analyses. Br. Med. J. 1988; 296:1369–1371. [22]

Maclure, M. and Willett, W.C. Misinterpretation and misuse of the kappa statistic. Am. J. Epidemiol. 1987; 126:161–169. [20]

MacMahon, B., Yen, S., Trichopoulos, D. et al. Coffee and cancer of the pancreas. N. Engl. J. Med. 1981; 304:630–633. [25]

Mahalanobis, P.C. Errors of observation in physician measurements. Sci. Cult. 1940; 7:443–445. [20] Maheswaran, R., Beevers, M., and Beevers, D.G. Effectiveness of advice to reduce alcohol consump -

tion in hypertensive patients. Hypertension 1992; 19:79–84. [29]

Makuch, R. and Simon, R. Sample size requirements for evaluating a conservative therapy. Cancer Treat. Rep. 1978; 62:1037–1040. [24]

Makuch, R.W. and Johnson, M.F. Some issues in the design and interpretation of “negative” clinical studies. Arch. Int. Med. 1986; 146:986–989. [24]

Makuch, R.W., Rosenberg, P.S., and Scott, G. Goodman and Kruskal’s λ : A new look at an old measure of association. Stat. Med. 1989; 8:619–631. [27]

Malkin, D., Li, F.P., Strong, L.C. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233–1238. [21]

Mann, H.B. and Whitney, D.R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Statist. 1947; 18:50–60. [15]

Mann, J., Holdstock, G., Harman, M., Machin, D., and Loehry, C.A. Scoring system in improve cost effectiveness of open access endoscopy. Br. Med. J. 1983; 287:937–940. [21]

Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 1966; 50:163–170. [22]

Mantel, N. Ridit analysis and related ranking procedures—Use at your own risk. Am. J. Epidemiol. 1979; 109:25–29. [15]

Mantel, N. and Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959; 22:719–748. [25,26]

Manton, K.G., Patrick, C.H., and Stallard, E. Population impact of mortality reduction: The effects of elimination of major causes of death on the “saved” population. Int. J. Epidemiol. 1980; 9:111–120. [22]

Mapes, R.E.A. Verbal and numerical estimates of probability in therapeutic contexts. Soc. Sci. Med. 1979; 13A:277–282. [6]

Margolick, J.B., Munoz, A., Vlahov, D. et al. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Arch. Intern. Med. 1994; 154:869–875. [16]

Margolis, J.R., Gillum, R.F., Feinleib, M., Brasch, R.C., and Fabsitz, R.R. Community surveillance for coronary heart disease: The Framingham Cardiovascular Disease Survey. Methods and preliminary results. Am. J. Epidemiol. 1974; 100:425–436. [22]

Mason, J.H., Anderson, J.J., and Meenan, R.F. A model of health status for rheumatoid arthritis. A factor analysis of the arthritis impact measurement scales. Arthritis Rheum. 1988; 31:714–720. [28]

Matthews, D.E. and Farewell, V.T. Using and Understanding Medical Statistics. 2nd ed. New York: Karger, 1988. [22]

Matthews, J.N.S., Altman, D.G., Campbell, M.J., and Royston, P. Analysis of serial measurements in medical research. Br. Med. J. 1990; 300:230–235. [22]

Mazur, D.J. and Merz, J.F. How age, outcome severity, and scale influence general medicine clinic patients’ interpretations of verbal probability terms. J. Gen. Intern. Med. 1994; 9:268–271. [6] McFarlane, M.J., Feinstein, A.R., and Horwitz, R.I. Diethylstilbestrol and clear cell vaginal carcinoma.

Reappraisal of the epidemiologic evidence. Am. J. Med. 1986; 81:855–863. [17]

© 2002 by Chapman & Hall/CRC

McFarlane, M.J., Feinstein, A.R., Wells, C.K., and Chan, C.K. The “epidemiologic necropsy.” Unex - pected detections, demographic selections, and changing rates of lung cancer. J. Am. Med. Assn. 1987; 258:331–338. [17]

McGill, R., Tukey, J.W., and Larsen, W.A. Variations of box plots. Am. Statist. 1978; 32:12–16. [5,16] McLean, J., Ciurczak, F. Bimanual dexterity in major league baseball players: A statistical study

(Letter to editor). New Engl. J. Med. 1982; 307:1278–1279. [27]

McNeil, B.J., Keeler, E., and Adelstein, S.J. Primer on certain elements of medical decision making. N. Engl. J. Med. 1975; 293:211–215. [21]

McNemar, Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947; 12:153–157. [20]

McNemar, Q. Psychological Statistics. New York: John Wiley and Sons, 1955. [20]

McPherson, K. Statistics: The problem of examining accumulating data more than once. N. Engl. J. Med. 1974; 290:501–502. [25]

Meinert, C.L. Meta-analysis: Science or religion? Controlled Clin. Trials. 1989; 10:257S–263S. [25] Merrell, M. Time-specific life tables contrasted with observed survivorship. Biometrics 1947;

3:129–136. [22]

Metz, C.E., Goodenough, D.J., and Rossmann, K. Evaluation of receiver operating characteristic curve data in terms of information theory, with applications in radiography. Radiology 1973; 109:297–303. [21]

Metzler, C.M. Bioavailability—A problem in equivalence. Biometrics 1974; 30:309–317. [24] Micceri, T. The unicorn, the normal curve, and other improbable creatures. Psychol. Bull. 1989;

105:156–166. [6]

Miettinen, O. Estimability and estimation in case-referent studies. Am. J. Epidemiol. 1976; 103:226–235. [14,17]

Miller, J.N. Outliers in experimental data and their treatment. Analyst 1993; 118:455–461. [5] Miller, R.G. Simultaneous Statistical Inference. New York: McGraw-Hill, 1966. [25]

Mills, J.L. Data torturing. N. Engl. J. Med. 1993; 329:1196–1199. [25]

Mohr, R., Smolinsky, A., and Goor, D. Treatment of nocturnal angina with 10° reverse trendelenburg bed position. Lancet 1982; 1:1325–1327. [13]

Moller-Petersen, J. Nomogram for predictive values and efficiencies of tests (Letter to editor). Lancet 1985; 1:348. [21]

Moorman, P.W., Siersema, P.D., de Ridder, M.A.J., and van Ginneken, A.M. How often is large smaller than small? (Letter to editor). Lancet 1995; 345:865. [6]

Morinelli, D., Levine, M.S., and Young, M. Importance of sample size for statistical significance (Letter to editor). Am. J. Radiol. 1984; 143:923–924. [23]

Mormor, M., Friedman-Kien, A., Laubenstein, L. et al. Risk factors for Kaposil’s sarcoma in homosexual men. Lancet 1982; 1:1083–1086. [19]

Morris, J.A. and Gardner, M.J. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br. Med. J. 1988; 296:1313–1316. [26]

Morrison, D.E. and Henkel, R.E. The Significance Test Controversy. Chicago: Aldine Publishing Co., 1970. [11]

Moses, L.E., Emerson, J.D., and Hosseini, H. Analyzing data from ordered categories. N. Engl. J. Med. 1984; 311:442–448. [15,27]

Mosteller, F. and Youtz, C. Quantifying probabilistic expressions. Statist. Sci. 1990; 5:2–12. [6] Mulder, P.G.H. An exact method for calculating a confidence interval of a Poisson parameter (Letter

to editor). Am. J. Epidemiol. 1983; 117:377. [26]

Mulvihill, J.J., Myers, M.H., Connelly, R.R. et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987; 3:813–817. [15]

Nakao, M.A and Axelrod, S. Numbers are better than words. Verbal specifications of frequency have no place in medicine. Am. J. Med. 1983; 74:1061–1065. [6]

Naylor, C.D., Chen, E., and Strauss, B. Measured enthusiasm: Does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann. Intern. Med. 1992; 117:916–921. [10] Nelson, D.E., Sacks, J.J., and Chorba, T.L. Required vision testing for older drivers (Letter to editor).

N. Engl. J. Med. 1992; 326:1784–1785. [16]

© 2002 by Chapman & Hall/CRC

Newman, D. The distribution of the range in samples from a normal population in terms of an independent estimate of standard deviation. Biometrika 1939; 31:20–30. [25]

Newman, L.G., Waller, J., Palestro, C.J. et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with Indium in 111 Oxyquinoline. JAMA 1991; 266:1246–1251. [9]

New Yorker Magazine, 1991. [16]

Neyman, J. and Pearson, E.S. On the use and interpretation of certain test criteria for the purposes of statistical inference. Biometrika 1928; 20:175–240. [23]

Nickol, K. and Wade, A.J. Radiographic heart size and cardiothoracic ratio in three ethnic groups: a basis for a simple screening test for cardiac enlargement in men. Br. J. Radiol. 1982; 55:399–403. [16]

Noether, G.E. Why Kendall tau? Teach. Statist. 1981; 3:41–43. [27]

The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med. 1981; 304:801–807. [14]

O’Brien, P.C. and Fleming, T.R. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549–556. [25]

O’Brien, P.C. and Shampo, M.A. Statistical considerations for performing multiple tests in a single experiment. 6. Testing accumulating data repeatedly over time. Mayo Clin. Proc. 1988; 63:1245–1249. [25]

Oden, N. Morphology of the normal visual field in a population-based random sample: Principal components analysis. Stat. Med. 1992; 11:1131–1150. [28]

O’Quigley, J. and Baudoin, C. General approaches to the problem of bioequivalence. Statistician 1988; 37:51–58. [24]

Oski, F. et al. Iron-fortified formulas and gastrointestinal symptoms in infants: A controlled study. Pediatrics 1980; 66:168–170. [24]

Osterziel. K.J., Dietz, R., Schmid, W., Mikulaschek, K., Manthey, J., and Kubler, W. ACE inhibition improves vagal reactivity in patients with heart failure. Am. Heart J. 1990; 120:1120–1129. [19] Oxford English Dictionary, Compact Edition. Micrographic reproduction. 1971. Oxford: Clarendon

Press, 835. [29]

Pascoe, J.M. Was it a type II error? (Letter to editor). Pediatrics 1981; 68:149. [24]

Passey, M.M. The effects of polyunsaturated fat vs. monounsaturated fat on plasma lipoproteins: The power of a study (Letter to editor). JAMA 1990; 264:2071. [23]

Paul, S., Bojanczyk, M., and Lanphear, J.H. Learning preferences of medical students. Med. Educ. 1994; 28:180–186. [29]

Peacock, J.L., Bland, J.M., and Anderson, H.R. Preterm delivery: Effects of socioeconomic factors, psychological stress, smoking, alcohol, and caffeine. Br. Med. J. 1995; 311:531–536. [28]

Pearson, E.S. Some thoughts on statistical inference. Ann. Math. Statist. 1962; 33:394–403. [23] Pearson, E.S. Quoted in Edwards, A.W.F. Likelihood. Cambridge: Cambridge University Press, 1976,

v. [23]

Peduzzi, P., Concato, J., Feinstein, A.R., and Holford, T.R. Importance of “events per independent variable” in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 1995; 48:1503–1510. [8]

Persico, M., Luzar, V., Saporaso, N., and Coltorti, M. Histologic reclassification of chronic viral hepatitis. A cluster analysis. Medic 1993; 1:23–27. [28]

Petersen, E.A., Alling, D.W., and Kirkpatrick, C.H. Treatment of chronic mucocutaneous candidiasis with ketoconazole. Ann. Intern. Med. 1980; 93:791–795. [14]

Petiti, D.D. Meta-analysis of non-experimental studies: Problems and prospects. Am. J. Epidemiol. 1993; 138:672 (Abstract). [25]

Peto, R., Gray, R., Collins, R. et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br. Med. J. 1988; 296:13–16. [10,24]

Peto, R. and Peto, J. Asymptomatically efficient rank invariant test procedures. J. Roy. Statist. Soc. Series A Stat. 1972; 135:185–206. [22]

Peto, R., Pike, M.C., Armitage, P. et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 1977; 35:1–39. [22]

© 2002 by Chapman & Hall/CRC

Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R. et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br. J. Cancer 1976; 34:585–612. [25]

Pickle, L.W. (Ed.). Atlas of United States Mortality. DHHS pub. no. (PHS) 97–1015. Washington, DC: U.S. Printing Office, 1996. [25]

Pillo-Blocka, F., Jurimae, K., Khoshoo, V., and Zlotkin, S. How much is “a lot” of emesis? (Letter to editor). Lancet 1991; 337:311–312. [6]

Pitman, E.J.G. Significance tests which may be applied to samples from any population. J. Roy. Statist. Soc. Series B Metho. 1937; 4:119–130. [12]

Plewis, II. Analysing Change: Measurement and Explanation Using Longitudinal Data. New York: John Wiley and Sons, 1985. [22]

Pocock, S.J. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191–199. [25]

Pocock, S.J. When to stop a clinical trial. Br. Med. J. 1992; 305:235–240. [25]

Pocock, S.J., Gore, S.M., and Kerr, G.R. Long term survival analysis: The curability of breast cancer. Stat. Med. 1982; 1:93–104. [22]

Poole, C., Lanes, S., and Rothman, K.J. Analyzing data from ordered categories (Letter to editor). N. Engl. J. Med. 1984; 311:1382. [27]

Prentice, R.L. and Marek, P. A qualitative discrepancy between censored data rank tests. Biometrics 1979; 35:861–867. [22]

Prosnitz, L.R. Radiotherapy for lung cancer (Letter to editor). Ann. Intern. Med. 1991; 114:95–96. [23] Quenouille, M.H. Approximate tests of correlation in time series. J. Roy. Statist. Soc. Ser. B. Metho.

1949; 11:18–84. [6]

Raju, T.N.K., Langenberg, P., and Sen, A. Treatment effect size in clinical trials: An example from surfactant trials. Controlled Clin. Trials 1993; 14:467–470. [10]

Ramirez, L., Arauz-Pacheco, C., Lackner, C., Albright, G., Adams, B., and Raskin, P. Lipoprotein (a) levels in diabetes mellitus: Relationship to metabolic control. Ann. Intern. Med. 1992; 117:42–47. [27]

Ransohoff, D.F. and Feinstein, A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N. Engl. J. Med. 1978; 299:926–930. [21]

Reaven, G.M. and Chen, Y-D.I. Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. Am. J. Med. 1988; 85:106–112. [19]

Reger, R.B., Petersen, M.R., and Morgan, W.K. Variation in the interpretation of radiographic change in pulmonary disease. Lancet 1974; 1:111–113. [20]

Reid, M.C., Lachs, M.S., and Feinstein, A.R. Use of methodological standards in diagnostic test research. JAMA 1995; 274:645–651. [21]

Reid, M.C., Lane, D.A., and Feinstein, A.R. Academic calculations versus clinical judgments: Practicing physicians’ use of quantitative measures of test accuracy. Am. J. Med. 1998; 104:374–380. [21]

Resseguie, L.J. Comparison of longitudinal and cross-sectional analysis: Maternal age and stillbirth ratio. Am. J. Epidemiol. 1976; 103:551–559. [22]

Reynolds, T., Nix, B., and Dunstan, F. Use of MoMs in medical statistics (Letter to editor). Lancet 1993; 341:359. [5]

Ries, A.L., Kaplan, R.M., and Blumberg, E. Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease. J. Clin. Epidemiol. 1991; 44:497–503. [28]

Risch, N. Genetic linkage: Interpreting lod scores. Science 1992; 255:803–804. [17]

Robbins, J.A. Subspecialty choice and faculty income (Letter to editor). J. Gen. Intern. Med. 1993; 8:401. [27]

Roberts, C.J. and Powell, R.G. Interrelation of the common congenital malformations. Lancet 1975; 2:849. [9]

Robertson, W.O. Quantifying the meanings of words. J. Am. Med. Assn. 1983; 249:2631–2632. [6] Robinson, W.B. The statistical measurement of agreement. Amer. Sociol. Rev. 1957; 22:17–25. [20] Rodda, B.E. and Davis, R.L. Determining the probability of an important difference in bioavailability.

Clin. Pharmacol. Ther. 1980; 28:247–252. [24]

© 2002 by Chapman & Hall/CRC

Rodriguez, B.L., Masaki, K., Burchfiel, C., Curb, J.D., Fong, K-O, Chyou, P-H, and Marcus, E.B. Pulmonary function decline and 17-year total mortality: The Honolulu heart program. Am. J. Epidemiol. 1994; 140:398–408. [22]

Roebruck, P. and Kuhn, A. Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities. Stat. Med. 1995; 14:1583–1594. [24]

Roos, N.P., Wennberg, J.E., Malenka, D.J., et al. Mortality and reoperation after open and transure - thral resection of the prostate for benign prostatic hyperplasia. N. Engl. J. Med. 1989; 320:1120–1124. [26]

Rosenthal, R. Meta-Analytic Procedures for Social Research. (Rev. ed.) Newbury Park: Sage Publications, 1991. [25]

Rossen, R.M., Goodman, D.J., Ingham, R.E., and Popp, R.L. Ventricular systolic septal thickening and excursion in idiopathic hypertrophic subaortic stenosis. N. Engl. J. Med. 1974; 291:317–319. [10]

Rosvoll, R.V., Mengason, A.P., Smith, L., Patel, H.J., Maynard, J., and Connor, F. Visual and automated differential leukocyte counts. A comparison study of three instruments. Am. J. Clin. Path. 1979; 71:695–703. [21]

Rothman, K.J. Modern Epidemiology. Boston: Little, Brown & Co., 1986. [26]

Rothman, K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1:43–46. [25]

Royal College of General Practitioners. Oral Contraceptives and Health: An Interim Report from the Oral Contraception Study. London: Pitman Medical, 1974. [26]

Royall, R.M. Ethics and statistics in randomized clinical trials (with discussion). Statist. Science 1991; 12:277–292. [25]

Royston, P. A toolkit for testing non-normality in complete and censored samples. Statistician 1993a; 42:37–43. [5]

Royston, P. Graphical detection of non-normality by using Michael’s statistic. Appl. Statist. 1993b; 42:153–158. [5]

Rozanski, A., Diamond, G.A., Berman, D. et al. The declining specificity of exercise radionuclide ventriculography. N. Engl. J. Med. 1983; 309:518–522. [21]

Ruel, M.T., Habicht, J.-P., Pinstrup-Andersen, P., and Grohn, Y. The mediating effect of maternal nutrition knowledge on the association between maternal schooling and child nutritional status in Lesotho. Am. J. Epidemiol. 1992; 135:904–914. [4]

Rumke, C.L. Implications of the statement: No side effects were observed (Letter to editor). N. Engl. J. Med. 1975; 292:372–373. [8]

Runyon, B.A., Montano, A.A., Akriviadis, E.A., Antillon, M.R., Irving, M.A., and McHutchison, J.G. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann. Intern. Med. 1992; 117:215–220. [16]

Saad, M.F., Lillioja, S., Nyomba, B.L. et al. Racial differences in the relation between blood pressure and insulin resistance. N. Engl. J. Med. 1991; 324:733–739. [19]

Sabia, P., Powers, E., Ragosta, M., Sarembock, I., Burwell, L., and Kaul, S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N. Engl. J. Med. 1992; 327:1825–1831. [27]

Sackett, D.L. Applying overviews and meta-analyses at the bedside. J. Clin. Epidemiol. 1995; 48:61–66. [25]

Sackett, D.L. and Cook, R.J. Understanding clinical trials. What measures of efficacy should journal articles provide busy clinicians? Brit. Med. J. 1994; 309:755–756. [10]

Sackett, D.L, Haynes, R.B., Guyatt, G.H., and Tugwell, P. Clinical Epidemiology. A Basic Science for Clinical Medicine. 2nd. ed. Boston: Little, Brown and Co., 1991. [1,21]

Sakia, R.M. The Box-Cox transformation technique: A review. Statistician 1992; 41:169–178. [3] Salsburg, D. Hypothesis versus significance testing for controlled clinical trials: A dialogue. Statist.

Med. 1990; 9:201–211. [23]

Sanchez-Guerrero, J., Colditz, G.A., Karlson, E.W., Hunter, D.J., Speizer, F.E., and Liang, M.H. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N. Engl. J. Med. 1995; 332:1666–1670. [25]

© 2002 by Chapman & Hall/CRC

Sanderson, C. and McKee, M. Commentary: How robust are rankings? The implications of confidence intervals. Br. Med. J. 1998; 316:1705. [7]

SAS Procedures Guide. Chapter 42, The Univariate Procedure. Ver. 6, 3rd ed. Cary, NC: SAS Institute, Inc., 1990, 617–634. [5]

Saudia, T.L., Barfield, B.R., and Barger, J. Effect of oat bran consumption on total serum cholesterol levels in healthy adults. Milit. Med. 1992; 157:567–568. [29]

Saunders, J., Baron, M.D., Shenouda, F.S., and Sonksen, P.H. Measuring glycosylated haemoglobin concentrations in a diabetic clinic. Br. Med. J. 1980; 281:1394. [20]

Savage, I.R. Contributions to the theory of rank order statistics—The two-sample case. Ann. Math. Statist. 1956; 27:590–615. [22]

Savitz, D.A. and Olshan, A.F. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am. J. Epidemiol. 1995; 142:904–908. [25]

Sawada, S, Sugai, S., Iijima, S. et al. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjogren’s Syndrome. Am. J. Med. 1992; 92:134–140. [27]

Schacker, T.W., Hughes, J.P., Shea, T., Coombs, R.W., and Corey, L. Biological and virologic characteristics of primary HIV infection. Ann. Intern. Med. 1998; 128:613–620. [19]

Scheffe, H. A method of judging all contrasts in the analysis of variance. Biometrika 1953; 40:87–104. [25]

Schlesselman, J.J. Case-Control Studies. New York: Oxford University Press, 1982. [26]

Schlundt, D.G., Taylor, D., Hill, J.O., Sbrocco, T., Pope-Cordle, J., Kasser, T., and Arnold, D. A behavioral taxonomy of obese female participants in a weight-loss program. Am. J. Clin. Nutr. 1991; 53:1151–1158. [28]

Schulz, H.-U. and Steinijans, V.W. Striving for standards in bioequivalence assessment: A review. Int. J. Clin. Ther. Toxicol. 1991; 29:293–298. [24]

Schulze, R.A., Jr., Rouleau, J., Rigo, P., Bowers, S., Strauss, H.W., and Pitt, B. Ventricular arrhythmias in the late hospital phase of acute myocardial infarction. Relation to left ventricular function detected by gated cardiac blood pool scanning. Circulation 1975; 52:1006:1011. [9]

Schulzer, M., Anderson, D.R., and Drance, S.M. Sensitivity and specificity of a diagnostic test determined by repeated observations. J. Clin. Epidemiol. 1991; 44:1167–1179. [21]

Schwartz, D. and Lellouch, J. Exploratory and pragmatic attitudes in therapeutic trials. J. Chron. Dis. 1967; 20:637–648. [23]

Sechi, L.A., Zingaro, L., DeCarli, S., Sechi, G., Catena, C., Falleti, E., Dell’Anna, E., and Bartoli, E. Increased serum lipoprotein(a) levels in patients with early renal failure. Ann. Intern. Med. 1998; 129:456–461. [19]

Seregard, S. Cell proliferation as a prognostic indicator in conjunctival malignant melanoma. Am. J. Ophthalmol. 1993; 116:93–97. [29]

Shann, F. Nutritional indices: Z, centile, or percent? Lancet 1993; 341:526–527. [4]

Shannon, C.E. A mathematical theory of communication. Bell Syst. Tech. J. 1948; 27:379–423, 623–656. [5]

Shapiro, S. Meta-analysis/Shmeta-analysis. Am. J. Epidemiol. 1994; 140:771–778. [25]

Sheikh, K.H., Bengtson, J.R., Rankin, J.S., de Bruijn, N.P., and Kisslo, J. Intraoperative transesophageal Doppler color flow imaging used to guide patient selection and operative treatment of ischemic mitral regurgitation. Circulation 1991; 84:594–604. [20]

Sheiner, L.B. The intellectual health of clinical drug evaluation. Clin. Pharmacol. Ther. 1992; 52:104–106. [29]

Sheppard, H., Winkelstein, W., Lang, W., and Charlebois, E. CD4+ T-lymphocytopenia without HIV infection (Letter to editor). N. Engl. J. Med. 1993; 328:1847–1848. [16]

Sheps, M.C. Shall we count the living or the dead. N. Engl. J. Med. 1958; 259:1210–1214. [10] Sherrill, D.L., Lebowitz, M.D., Knudson, R.J., and Burrows, B. Longitudinal methods for describing

the relationship between pulmonary function, respiratory symptoms and smoking in elderly subjects: The Tucson Study. Eur. Respir. J. 1993; 6:342–348. [22]

Shrout, P.E. and Fleiss, J.L. Intraclass correlations: Uses in assessing rater reliability. Psychol. Bull. 1979; 86:420–428. [29]

Siegel, S, and Castellan, N.J., Jr. Non-Parametric Statistics for the Behavioral Sciences. 2nd ed. New York: McGraw-Hill Book Co., 1988. [15,20,27]

© 2002 by Chapman & Hall/CRC